Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients

Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients

Copyright © 2020 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 218(2020) vom: 20. Sept., Seite 108492
1. Verfasser: Ma, Qian (VerfasserIn)
Weitere Verfasser: Ran, Hao, Li, Yingkai, Lu, Yaru, Liu, Xiaoxi, Huang, Huan, Yang, Wenhao, Yu, Lu, Chen, Pei, Huang, Xin, Qiu, Li, Lin, Zhongqiang, Ou, Changyi, Liu, Weibin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't AChR-MG Biomarker Circulating Th1/17 cells Early intervention Plasticity of Th17 cells Pro-inflammatory Biomarkers Receptors, Cholinergic
Online verfügbar Volltext